Clinical trial

Differential Effects of Vasopressin and Oxytocin on Attention Control

NCT04715737

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Vasopressin Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Oxytocin Normalized identity: oxytocinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Differential Effects of Vasopressin and Oxytocin on Attention Control

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-12-19

PhaseNA

Conditions

Healthyunresolved

Interventions

VasopressinDRUG

OxytocinDRUG · verified · RxNorm: oxytocin

PlaceboDRUG

Sponsors & collaborators

University of Electronic Science and Technology of Chinalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04715737 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.